Predictors of Mortality in Patients With Cardiovascular Implantable Electronic Device Infections

被引:73
|
作者
Habib, Ammar [1 ]
Le, Katherine Y. [1 ]
Baddour, Larry M. [2 ]
Friedman, Paul A. [3 ]
Hayes, David L. [3 ]
Lohse, Christine M. [4 ]
Wilson, Walter R. [2 ]
Steckelberg, James M. [2 ]
Sohail, M. Rizwan [2 ]
机构
[1] Mayo Clin, Mayo Sch Grad Med Educ, Rochester, MN USA
[2] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Med, Div Cardiovasc Dis, Rochester, MN USA
[4] Mayo Clin, Coll Med, Dept Biostat & Informat, Rochester, MN USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 111卷 / 06期
关键词
RISK; PACEMAKER; OUTCOMES;
D O I
10.1016/j.amjcard.2012.11.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infection reduces survival in cardiovascular implantable electronic device (CIED) recipients. However, the clinical predictors of short- and long-term mortality in patients with CIED infection are not well understood. We retrospectively reviewed all patients with CIED infection who were admitted to Mayo Clinic from January 1991 to December 2008. Survival data were obtained from the medical records and the United Sates Social Security Index. The purported risk factors for short-term (30-day) and long-term (>30-day) mortality were analyzed using univariate and multivariate models. Overall, 415 cases of CIED infection were identified during the study period. The mean follow-up duration for the 243 patients who were alive at the last follow-up visit was 6.9 years. In a multivariate model, heart failure (odds ratio 9.31, 95% confidence interval 2.08 to 41.67), corticosteroid therapy (odds ratio 4.04, 95% confidence interval 1.40 to 11.60), and presentation with CIED-related infective endocarditis (odds ratio 5.60, 95% confidence interval 2.25 to 13.92) were associated with increased short-term mortality. The factors associated with long-term mortality in the multivariate model included patient age (hazard ratio 1.20, 95% confidence interval 1.06 to 1.36), heart failure (hazard ratio 2.01, 95% confidence interval 1.42 to 2.86), metastatic malignancy (hazard ratio 5.99, 95% confidence interval 1.67 to 21.53), corticosteroid therapy (hazard ratio 1.97, 95% confidence interval 1.22 to 3.18), renal failure (hazard ratio 1.94, 95% confidence interval 1.37 to 2.74), and CIED-related infective endocarditis (hazard ratio 1.68, 95% confidence interval 1.17 to 2.41). In conclusion, these data suggest that the development of CIED-related infective endocarditis and the presence of co-morbid conditions are associated with increased short- and long-term mortality in patients with CIED infection. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111:874-879)
引用
收藏
页码:874 / 879
页数:6
相关论文
共 50 条
  • [31] Associations and Outcomes of Cardiovascular Implantable Electronic Device Infections in a Tertiary Referral Centre
    Tweedie, J.
    McGeehan, P.
    Wilson, C.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S431 - S432
  • [32] Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves
    Huang, Xin-miao
    Fu, Hai-xia
    Zhong, Li
    Cao, Jiang
    Asirvatham, Samuel J.
    Baddour, Larry M.
    Sohail, M. Rizwan
    Nkomo, Vuyisile T.
    Nishimura, Rick A.
    Greason, Kevin L.
    Suri, Rakesh M.
    Friedman, Paul A.
    Cha, Yong-Mei
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (09):
  • [33] Long-term Mortality After Cardiovascular Implantable Electronic Device Infection
    Reddy, Madhu
    Chaung, Jenna
    Boolani, Hemant
    Atrouni, Wissam
    Atkins, Donita
    Bommana, Sudharani
    Pimentel, Rhea
    Emert, Martin
    Berenbom, Loren
    Vacek, James
    Lakkireddy, Dhanunjaya
    Dendi, Raghuveer
    [J]. CIRCULATION, 2012, 126 (21)
  • [34] Cardiovascular electronic device infections
    Kolodzinska, Agnieszka
    Kutarski, Andrzej
    Grabowski, Marcin
    Opolski, Grzegorz
    [J]. KARDIOLOGIA POLSKA, 2013, 71 (06) : 623 - 630
  • [35] Predictors of pacing-dependency in patients with cardiovascular implantable electronic devices
    Grimm, Wolfram
    Grimm, Kathrin
    Greene, Brandon
    Parahuleva, Mariana
    [J]. CARDIOLOGY JOURNAL, 2021, 28 (03) : 423 - 430
  • [36] Trends in Management Practices of Cardiovascular Implantable Electronic Device Infections in Patients With End-Stage Kidney Disease
    Jiwani, Sania
    Chan, Wan-Chi
    Pothuru, Suveenkrishna
    Reddy, Madhu
    Pimentel, Rhea C.
    Gupta, Kamal
    [J]. CIRCULATION, 2023, 148
  • [37] How to diagnose and manage patients with cardiac implantable electronic device infections
    Tarakji, Khaldoun G.
    Wilkoff, Bruce L.
    [J]. JOURNAL OF ARRHYTHMIA, 2013, 29 (06) : 320 - 324
  • [38] Microbiology of cardiac implantable electronic device infections
    Bongiorni, Maria Grazia
    Tascini, Carlo
    Tagliaferri, Enrico
    Di Cori, Andrea
    Soldati, Ezio
    Leonildi, Alessandro
    Zucchelli, Giulio
    Ciullo, Ilaria
    Menichetti, Francesco
    [J]. EUROPACE, 2012, 14 (09): : 1334 - 1339
  • [39] Diagnostic evaluation and management of culture-negative cardiovascular implantable electronic device infections
    Garrigos, Zerelda Esquer
    George, Merit P.
    Farid, Saira
    Abu Saleh, Omar M.
    Vijayvargiya, Prakhar
    Mahmood, Maryam
    Friedman, Paul A.
    Steckelberg, James M.
    DeSimone, Daniel C.
    Wilson, Walter R.
    Baddour, Larry M.
    Sohail, M. Rizwan
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (08): : 933 - 942
  • [40] Clinical Features and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Staphylococcal Species
    Le, Katherine Y.
    Sohail, Muhammad R.
    Friedman, Paul A.
    Uslan, Daniel Z.
    Cha, Stephen S.
    Hayes, David L.
    Wilson, Walter R.
    Steckelberg, James M.
    Baddour, Larry M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (08): : 1143 - 1149